Acucela Inc. (TOKYO: 4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, today announced that its 2015 Annual Meeting of Shareholders will be held on Monday, June 8, 2015 at Acucela’s headquarters in Seattle, Washington, at 1:00PM Pacific Time for shareholders of record as of March 31, 2015.
Help employers find you! Check out all the jobs and post your resume.
